Capstone Partners (IMAP USA) advised ToxStrategies — a multidisciplinary scientific consulting firm — on its recapitalization to Renovus Capital. 

ToxStrategies, is a scientific consulting firm specializing in toxicology, epidemiology, regulatory compliance, and safety. The company has a strong reputation for scientific excellence and advancing innovative solutions to address the complex regulatory and technical challenges confronting its clients in sectors including pharmaceuticals, biotechnology, medical devices, food and additives, chemical, government, and consumer products. With unique capabilities in assessing potential health effects and exposure to chemicals, biological contaminants, natural products, radionuclides, and pharmaceutical and biopharmaceutical products, ToxStrategies is a valued partner for both public and blue-chip private clients.